All eyes now on UK start-up VC (venture capital) debate, while Boots buy-out sets PE precedent
This article was originally published in Clinica
Executive Summary
Over the last week, there has been a flurry of private equity (PE) sector activity affecting the healthcare industry, with the heads of several of the world's most powerful funds getting "a grilling", the Boots acquisition getting two final OKs, and investment-for-growth venture capital (VC) getting a fresh look.